Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова» Минздрава России. 197022, Россия, Санкт-Петербург, ул. Льва Толстого, д. 6/8; 2СПб ГБУЗ «Центр по профилактике и борьбе со СПИД и инфекционными заболеваниями». 190103, Россия, Санкт-Петербург, наб. Обводного канала, д. 179А
Список исп. литературыСкрыть список 1. Сыропятов О.Г., Дзеружинская Н.А., Солдаткин В.А. и др. Психические и поведенческие расстройства при ВИЧ-инфекции и СПИДе. Учебное пособие. К.; Ростов-на-Дону; СПб., 2013. / Syropiatov O.G., Dzeruzhinskaia N.A., Soldatkin V.A. i dr. Psikhicheskie i povedencheskie rasstroistva pri VICh-infektsii i SPIDe. Uchebnoe posobie. K.; Rostov-na-Donu; SPb., 2013. [in Russian] 2. Treisman GJ, Angelino AF, Hutton HE. Psychiatric issues in the management of patients with HIV infection. JAMA 2001; 286: 2857–64. 3. Benton T, Blume J, Dubé B. Treatment Considerations for Psychiatric Syndromes Associated with HIV Infection. HIV Therapy 2010; 4 (2): 231–45. 4. Foster R, Olajide D, Everall IP. Antiretroviral therapy-induced psychosis: case report and brief review of the literature. HIV Medicine 2003; 4 (Issue 2): 139–44. 5. Blank MB, Himelhoch S, Walkup J, Eisenberg MM. Treatment Considerations for HIV-Infected Individuals with Severe Mental Illness. Curr HIV/AIDS Rep 2013; 10 (4): 371–9. 6. Bloom FE, Rausch DM. HIV in the brain: pathology and neurobehavioral consequences. J Neurovirol 1997; 3: 102–9. 7. Rabkin JG, Ferrando S. A second life agenda. Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome. Arch Gen Psychiatry 1997; 54: 1049–53. 8. Treismana GJ, Kaplina AI. Depression, Cognitive Impairment, Neurologic & Psychiatric Complications in HIV & Antiretroviral Drugs. AIDS 2002; 16: 1201–15. 9. Беляков Н.А., Незнанов Н.Г., Халезова Н.Б., Иванов А.Н. Распространенность психических расстройств у ВИЧ-инфицированных больных в Санкт-Петербурге с 2001 по 2013 годы. Междисциплинарный подход в понимании и лечении психических расстройств: миф или реальность? Под общ. ред. Н.Г.Незнанова. 2014; с. 374–6. / Beliakov N.A., Neznanov N.G., Khalezova N.B., Ivanov A.N. Rasprostranennost' psikhicheskikh rasstroistv u VICh-infitsirovannykh bol'nykh v Sankt-Peterburge s 2001 po 2013 gody. Mezhdistsiplinarnyi podkhod v ponimanii i lechenii psikhicheskikh rasstroistv: mif ili real'nost'? Pod obshch. red. N.G.Neznanova. 2014; s. 374–6. [in Russian] 10. Казаковцев Б.А., Демчева Н.К., Творогова Н.А. Психиатрическая помощь населению Российской Федерации в 2013 году: Аналитический обзор. М.: ФГБУ ФМИЦПН Минздрава России, 2015. / Kazakovtsev B.A., Demcheva N.K., Tvorogova N.A. Psikhiatricheskaia pomoshch' naseleniiu Rossiiskoi Federatsii v 2013 godu: Analiticheskii obzor. M.: FGBU FMITsPN Minzdrava Rossii, 2015. [in Russian] 11. Незнанов Н.Г., Халезова Н.Б. Шизофрения и ВИЧ: психосоциальные и клинические аспекты. ВИЧ-инфекция и иммуносупрессии. 2014; 6 (3): 46–57. / Neznanov N.G., Khalezova N.B. Shizofreniia i VICh: psikhosotsial'nye i klinicheskie aspekty. VICh-infektsiia i immunosupressii. 2014; 6 (3): 46–57. [in Russian] 12. Lyketsos G, Treisman GJ. Mood disorders in HIV infection. Psychiatric Ann 2001; 31: 45–9. 13. Mauri MC, Fabiano L, Bravin S et al. Schizophrenic patients before and after HIV infection: a case-control study. Encephale 1997; 23: 437–41. 14. Morrison MF, Petitto JM, Ten Have T et al. Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry 2002; 159: 5789–96. 15. Thompson A, Silverman B, Dzeng L, Treisman G. Psychotropic Medications and HIV. Clin Infect Dis 2006; 42 (Issue 9): 1305–10. 16. Maxwell S, Scheftner WA, Kessler HA, Busch K. Manic syndrome associated with zidovudine. JAMA 1988; 259 (23): 3406. 17. Letendre S, Ellis R, Deutech R et al. 17th Conference on retroviruses and Opportunistic Infections, San Francisco (Poster №430). 18. Психиатрия: национальное руководство. Под ред. Т.Б.Дмитриевой, В.Н.Краснова, Н.Г.Незнанова и др. М.: ГЭОТАР-Медиа, 2011. / Psikhiatriia: natsional'noe rukovodstvo. Pod red. T.B.Dmitrievoi, V.N.Krasnova, N.G.Neznanova i dr. M.: GEOTAR-Media, 2011. [in Russian] 19. Walkup J, Akincigil A, Hoover DR et al. Use of Medicaid Data to Explore Community Characteristics Associated with HIV Prevalence Among Beneficiaries with Schizophrenia. Public Health Rep 2011; 126 (Suppl. 3): 89–101. 20. Himelhoch S, Brown CH, Walkup J et al. HIV patients with psychiatric disorders are less likely to discontinue HAART. AIDS 2009; 23: 1735–42. 21. Nurutdinova D, Chrusciel T, Zeringue A et al. Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans. AIDS 2012; 26: 229–34. 22. Walkup JT, Akincigil A, Amin S et al. Prevalence of diagnosed HIV disease among medicaid beneficiaries with schizophrenia in U.S. metropolitan areas. J Nerv Ment Dis 2010; 198: 682–6. 23. Leucht S, Burkard T, Henderson J et al. Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 2007; 116: 317–33. 24. Nejad SH, Gandhi RT, Freudenreich O. Clozapine use in HIV-infected schizophrenia patients: a case-based discussion and review. Psychosomatics 2009; 50 (6): 626–32. DOI: 10.1176/appi. psy.50.6.626. 25. Bogart LM, Fremont AM, Young AS et al. Patterns of HIV care for patients with serious mental illness. AIDS Patient Care STDS 2006; 20: 175–82. 26. Daumit GL, Anthony CB, Ford DE et al. Pattern of mortality in a sample of Maryland residents with severe mental illness . Psychiatry Res 2010; 176: 242–5. 27. De Hert M, Correll CU, Bobes J et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 2011; 10: 52–77. 28. Chander G, Zhang Y, DosReis S et al. Is serious mental illness associated with earlier death among persons with HIV? Ten year follow up in Maryland Medicaid Recipients. J AIDS HIV Res 2012; 4 (8): 213–8. 29. Захарова Н.Г., Торопов С.Э., Пархоменко С.И. и др. Особенности назначения высокоактивной антиретровирусной терапии ВИЧ-инфицированным больным с нарушением функции центральной нервной системы. ВИЧ-инфекция и иммуносупрессии. 2014; 6 (1): 28–9. / Zakharova N.G., Toropov S.E., Parkhomenko S.I. i dr. Osobennosti naznacheniia vysokoaktivnoi antiretrovirusnoi terapii VICh-infitsirovannym bol'nym s narusheniem funktsii tsentral'noi nervnoi sistemy. VICh-infektsiia i immunosupressii. 2014; 6 (1): 28–9. [in Russian] 30. Van Oeffelt T, Prinsen EJ. Treatment-resistant psychosis due to interaction between ritonavir and olanzapine: case report and literature review. Tijdschr Psychiatr 2016; 58 (4): 309–13. 31. Nejad S, Gandhi RT, Freudenreich O. Clozapine use in HIV-infected schizophrenia patients: a case-based discussion and review. Psychosomatics 2009; 50 (6): 626–32. DOI: 10.1176/appi.psy. 50.6.626. 32. Wright N, Akhtar A, Tosh GE, Clifton AV. HIV prevention advice for people with serious mental illness. J Prev Interv Community 2007; 33 (1–2): 109–20. Schizophrenia, AIDS and the decision to prescribe HAART: results of a national survey of HIV clinicians. 33. Lundgren JD, Lene Ryom Clumeck N, Rockstroh J. EACS Guidelines version 7.0. – EACS European AIDS Clinical Society, 2013. URL: http://www.eacsociety.org/ Portals/0/Guidelines_Online_ 131014. pdf 34. Mollan KR, Smurzynski M, Eron JJ et al. Association between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk of Suicidal Ideation, Attempted, or Completed Suicide. Intern Med 2014; 161 (1): 1–10. 35. Ellis R, Letendre SL. Update and New Directions in Therapeutics for Neurological Complications of HIV Infections. Neurotherapeutics 2016; 13 (3): 471–6. 36. Letendre S. Central Nervous System Complications in HIV Disease: HIV-Associated Neurocognitive Disorder. Top Antivir Med 2011; 19 (4): 137–42. 37. Гайсина А.В. Патофизиологические механизмы формирования ВИЧ-ассоциированных нейрокогнитивных расстройств. Автореф. дис. … канд. биол. наук. 2011. / Gaisina A.V. Patofiziologicheskie mekhanizmy formirovaniia VICh-assotsiirovannykh neirokognitivnykh rasstroistv. Avtoref. dis. … kand. biol. nauk. 2011. [in Russian] 38. Hellmuth J, Valcour V, Spudich S. CNS reservoirs for HIV-implications for eradication. J Virus Erad 2015; 1 (2): 67–71. 39. Zayyad Z, Spudich S. Neuropathogenesis of HIV: From Initial Neuroinvasion to HIV Associated Neurocognitive Disorder (HAND). Curr HIV/AIDS Rep 2015; 12 (1): 16–24. 40. Gray LR, Cowley D, Welsh C et al. CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies. Molecular Psychiatry 2016; 21 (4): 574–84. 41. Vigorito M, Connaghan KP, Chang SL. The HIV-1 transgenic rat model of neuroHIV. Brain Behavior Immun 2015; 48: 336–49. 42. Лекарственные средства для лечения ВИЧ-инфекции. Под ред. Н.А.Белякова. ВИЧ/СПИД – информационно-аналитический бюллетень. СПб.: Балтийский медицинский образовательный центр, 2015. / Lekarstvennye sredstva dlia lecheniia VICh-infektsii. Pod red. N.A.Beliakova. VICh/SPID – informatsionno-analiticheskii biulleten'. SPb.: Baltiiskii meditsinskii obrazovatel'nyi tsentr, 2015. [in Russian] 43. Simoni JM, Safren SA, Manhart LE et al. Challenges in addressing depression in HIV research: assessment, cultural context, and methods. AIDS Behav 2011; 15 (2): 376–88. 44. Kessler RC, Birnbaum H, Bromet E et al. Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). Psychol Med 2010; 40 (2): 225–37.